Indivior (LON:INDV) Stock Price Passes Below Two Hundred Day Moving Average – Should You Sell?

Indivior PLC (LON:INDV) shares passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 1,238 and traded as low as GBX 1,230. Indivior shares last traded at GBX 1,238, with a volume of 8,457,898 shares.

Indivior Stock Up 1.6%

The company has a debt-to-equity ratio of -141.86, a current ratio of 0.90 and a quick ratio of 1.52. The firm’s 50-day simple moving average is GBX 1,238 and its two-hundred day simple moving average is GBX 1,238. The company has a market capitalization of £1.93 billion, a price-to-earnings ratio of -1,026.48, a price-to-earnings-growth ratio of -5.57 and a beta of 0.19.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose. Its core marketed products include SUBLOCADE and SUBUTEX PRO buprenorphine extended-release monthly injections; SUBOXONE, a buprenorphine and naloxone sublingual film; SUBOXONE, a buprenorphine and naloxone sublingual tablet; and SUBUTEX, a buprenorphine sublingual tablet for the treatment of opioid use disorder.